Can the Cell-free DNA Test Predict Placenta Accreta Spectrum or Placenta Previa Totalis?


Adiyaman D., Kuyucu M., Atakul B. K., Can D., Ozeren M., Koc A., ...Daha Fazla

ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, cilt.226, sa.02, ss.92-97, 2022 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 226 Sayı: 02
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1055/a-1579-1338
  • Dergi Adı: ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.92-97
  • Anahtar Kelimeler: cell-free DNA test, fetal fraction, placenta accreta spectrum, placenta previa, FREE FETAL DNA, MATERNAL PLASMA, PREGNANCIES, FRACTION, HEALTH
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Background Following the discovery that fetal DNA originates from the trophoblastic cells of the placenta, the contribution of the cell-free DNA test in placenta-related obstetric complications has begun to be investigated. Compared to uncomplicated pregnancies, higher fetal fractions were detected in placenta accreta spectrum and placenta previa, which are among placenta-related obstetric complications. However, this data applies only to advanced gestational weeks.